Stem Cell Factor Articles & Analysis

2 news found

Ankasa Regenerative Therapeutics Receives $8.5 Million in First Tranche of $17 Million Series A Financing Led by Avalon Ventures

Ankasa Regenerative Therapeutics, Inc. (Ankasa), a company focused on pharmaceutical preparations for reactivation of stem cells for organ and tissue regrowth, tissue repair and healing, has received $8.5 million in the first tranche of a $17 million Series A round of financing led by La Jolla-based Avalon Ventures. Other participants in the financing include Heraeus Medical, a global business ...

Jun. 23, 2015

ByAnkasa Regenerative Therapeutics

Arsenic turns stem cells cancerous, spurring tumor growth

Researchers at the National Institutes of Health have discovered how exposure to arsenic can turn normal stem cells into cancer stem cells and spur tumor growth. Inorganic arsenic, which affects the drinking water of millions of people worldwide, has been previously shown to be a human carcinogen. A growing body of evidence suggests that cancer is a stem-cell based disease. Normal stem cells are ...

Apr. 4, 2012

ByNational Institute of Environmental Health Sciences (NIEHS)

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you